CorMedix Therapeutics will announce its financial results for the second quarter ending June 30, 2026, before market open on August 13, 2026. The company will also host a corporate update conference call at 8:30 AM Eastern Time that day. This update is important for investors to assess CorMedix's recent performance and outlook. CorMedix focuses on developing and marketing therapeutic products for serious conditions in U.S. healthcare settings.
RBC Capital upgraded Rio Tinto to Sector Perform from Underperform, reflecting confidence in its lithium expansion and solid operational stability. The company is boosting lithium output to meet rising demand from electric vehicles and energy storage...
ASML continues to be a strong buy despite its premium valuation due to high demand for its EUV lithography machines, driven by AI development and memory chip shortages, especially High Bandwidth Memory (HBM). The shift to sub-2nm chip technology ensu...
Applied Optoelectronics stock surged 6% to $128.95 after completing a $600 million at-the-market equity program, which clears known share supply and strengthens its balance sheet. This is the company's third such program this year, aimed at funding e...
Kalshi withdrew its proposed Pepe (PEPE) perpetual futures contract just days after certification, before it became available for trading. The contract, named PEPEPERP, was certified on September 29 and withdrawn on October 1, meaning Pepe is not cur...
MTU Aero Engines AG reported a 13% revenue increase to €4.69 billion in the first half of 2026, driven by aftermarket growth that offset margin pressures from GTF maintenance. The company improved OEM margins despite lower sales and raised its cash c...
